2025 EARLY CAREERS COURSE IN CLINICAL ENDOCRINOLOGY

• ENRICO PAPINI· DIP. ENDO. E MET. OSP. REGINA APOSTOLORUM ROMA

• ANNE BECHELOT· RELATORE
• JEROME BERTHERAT· MODERATORE
• MASSIMO CAPRIO· MODERATORE
• MARCO CHIANELLI· RELATORE
• RENATO COZZI· MODERATORE
• SEBASTIEN CZERNICHOW· RELATORE
• COSIMO DURANTE· RELATORE
• ANTONGIULIO FAGGIANO· RELATORE
• ANDREA FRASOLDATI· MODERATORE
• LUIGI GENANRI· RELATORE
• FRANCO GRIMALDI· MODERATORE
• CHARLOTTE HOYBYE· MODERATORE
• PETER KOPP· RELATORE
• PAUL LIPS· RELATORE
• PIETRO MAFFEI· RELATORE
• ANDREA PALERMO· RELATORE
• ROSARIO PIVONELLO· RELATORE
• GIUSEPPE REIMONDO· MODERATORE
• DOMENICO RENDINA· MODERATORE
• ALFREDO SCILITANI· MODERATORE
• CHIARA SIMEOLI· MODERATORE
• GAIA TABACCO· MODERATORE
• WALTER VENA· MODERATORE
• FABIO VESCINI· RELATORE
• MARIA CHIARA ZATELLI· MODERATORE

Ragione sociale

DUECI PROMOTION S.R.L.

Stato accreditamento

STANDARD - 1° rinnovo

Di sistema

The addressed topics will be: • thyroid: replacement treatment for hypothyroidism. Use of thyroid kinase inhibitors for advanced thyroid cancer. • hypoparathyroidism: how to manage a neglected disease in 2025. • obesity: the landscape of new drugs, the tailored management for the individual patient and perspectives on monogenic obesities. • endogenous hypercortisolism: an update on clinical management. • bone metabolism: advanced treatment for osteoporosis and the clinical management of their side effects. • vitamin d deficiency: lights and shadows about guidelines • adrenogenital syndromes: the unmet needs. • neuroendocrine tumors: is there still a role for somatostatin receptor ligands?

#2Linee guida - protocolli - procedure

Area: Obiettivi formativi tecnico-professionali

Partecipanti max

80

Verifica presenza

Firma Di Presenza

Verifica apprendimento

Questionario A Risposta Multipla